Masugi Maruyama

2.9k total citations
100 papers, 2.3k citations indexed

About

Masugi Maruyama is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Masugi Maruyama has authored 100 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 32 papers in Cancer Research and 17 papers in Hematology. Recurrent topics in Masugi Maruyama's work include Protease and Inhibitor Mechanisms (27 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers) and Enzyme Production and Characterization (14 papers). Masugi Maruyama is often cited by papers focused on Protease and Inhibitor Mechanisms (27 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers) and Enzyme Production and Characterization (14 papers). Masugi Maruyama collaborates with scholars based in Japan, India and Thailand. Masugi Maruyama's co-authors include Harishkumar Madhyastha, Radha Madhyastha, Yuichi Nakajima, Hisashi Mihara, Masahiko Sugiki, Hiroyuki Sumi, Etsuo Yoshida, Sayuri Omura, Tomoyuki Yoneta and Masao Seiki and has published in prestigious journals such as Cancer, Journal of Hazardous Materials and Journal of Agricultural and Food Chemistry.

In The Last Decade

Masugi Maruyama

100 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masugi Maruyama Japan 29 984 385 337 277 194 100 2.3k
Maria Luíza Vilela Oliva Brazil 30 1.6k 1.6× 320 0.8× 158 0.5× 445 1.6× 98 0.5× 105 2.8k
Xiaoying Chen China 33 1.7k 1.8× 213 0.6× 476 1.4× 144 0.5× 116 0.6× 185 3.6k
Tianyuan Zhang China 34 1.8k 1.8× 197 0.5× 286 0.8× 181 0.7× 197 1.0× 139 3.3k
M. NAKAYAMA Japan 30 1.8k 1.9× 140 0.4× 1.0k 3.0× 96 0.3× 39 0.2× 89 4.2k
Muhammad Tariq Pakistan 29 1.3k 1.4× 146 0.4× 545 1.6× 72 0.3× 14 0.1× 121 3.8k
Liying Liu China 27 1.2k 1.2× 166 0.4× 509 1.5× 46 0.2× 56 0.3× 116 2.1k
Miroslav Blumenberg United States 39 2.2k 2.3× 590 1.5× 464 1.4× 57 0.2× 10 0.1× 117 5.2k
Mauro S.G. Pavão Brazil 31 1.2k 1.2× 159 0.4× 373 1.1× 562 2.0× 12 0.1× 81 3.2k
Jin Yang China 27 1.1k 1.1× 98 0.3× 345 1.0× 62 0.2× 31 0.2× 106 2.1k
Wentao Dai China 18 1.2k 1.2× 161 0.4× 244 0.7× 48 0.2× 28 0.1× 92 2.5k

Countries citing papers authored by Masugi Maruyama

Since Specialization
Citations

This map shows the geographic impact of Masugi Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masugi Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masugi Maruyama more than expected).

Fields of papers citing papers by Masugi Maruyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masugi Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masugi Maruyama. The network helps show where Masugi Maruyama may publish in the future.

Co-authorship network of co-authors of Masugi Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Masugi Maruyama. A scholar is included among the top collaborators of Masugi Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masugi Maruyama. Masugi Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madhyastha, Radha, Harishkumar Madhyastha, Masugi Maruyama, et al.. (2021). Retinoic acid attenuates nuclear factor kappaB mediated induction of NLRP3 inflammasome. Pharmacological Reports. 74(1). 189–203. 5 indexed citations
2.
Madhyastha, Harishkumar, Radha Madhyastha, Abhishek Thakur, et al.. (2020). c-Phycocyanin primed silver nano conjugates: Studies on red blood cell stress resilience mechanism. Colloids and Surfaces B Biointerfaces. 194. 111211–111211. 30 indexed citations
3.
Renu, Kaviyarasi, Arunraj Namachivayam, Harishkumar Madhyastha, et al.. (2020). An appraisal on molecular and biochemical signalling cascades during arsenic-induced hepatotoxicity. Life Sciences. 260. 118438–118438. 58 indexed citations
4.
Jain, Devendra, Harishkumar Madhyastha, Radha Madhyastha, et al.. (2018). Insight into the composition and surface corona reliant biological behaviour of quercetin engineered nanoparticles. Colloids and Surfaces A Physicochemical and Engineering Aspects. 548. 1–9. 24 indexed citations
5.
Navya, P. N., Harishkumar Madhyastha, Radha Madhyastha, et al.. (2018). Single step formation of biocompatible bimetallic alloy nanoparticles of gold and silver using isonicotinylhydrazide. Materials Science and Engineering C. 96. 286–294. 36 indexed citations
6.
Ahmad, Ahyar, et al.. (2018). Cloning and expression of MPT83 gene from Mycobacterium tuberculosis in E. coli BL21 as vaccine candidate of tuberculosis: A preliminary study. Journal of Genetic Engineering and Biotechnology. 16(2). 335–340. 6 indexed citations
7.
Madhyastha, Radha, Harishkumar Madhyastha, Yuichi Nakajima, Sayuri Omura, & Masugi Maruyama. (2011). MicroRNA signature in diabetic wound healing: promotive role of miR‐21 in fibroblast migration. International Wound Journal. 9(4). 355–361. 138 indexed citations
8.
Nakajima, Yuichi, Radha Madhyastha, & Masugi Maruyama. (2009). 2-Deoxy-D-Ribose, a Downstream Mediator of Thymidine Phosphorylase, Regulates Tumor Angiogenesis and Progression. Anti-Cancer Agents in Medicinal Chemistry. 9(2). 239–245. 22 indexed citations
9.
Madhyastha, Radha, et al.. (2009). Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract. Phytomedicine. 17(1). 42–46. 11 indexed citations
10.
Madhyastha, Harishkumar, et al.. (2008). uPA dependent and independent mechanisms of wound healing by C‐phycocyanin. Journal of Cellular and Molecular Medicine. 12(6b). 2691–2703. 50 indexed citations
11.
Madhyastha, Harishkumar, et al.. (2006). C-phycocyanin transcriptionally regulates uPA mRNA through cAMP mediated PKA pathway in human fibroblast WI-38 cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1760(11). 1624–1630. 12 indexed citations
12.
Hishikawa, Yoshitaka, Masugi Maruyama, Hiroshi Yokota, et al.. (2005). CONTAMINATION OF ARSENIC IN DRINKING WATER IN AYEYARWADY DELTA REGION, MYANMAR. 2019. 1 indexed citations
13.
14.
15.
Sugiki, Masahiko, et al.. (1998). Prostaglandin I2 analog enhances the expression of urokinase-type plasminogen activator and wound healing in cultured human fibroblast. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1403(2). 189–198. 22 indexed citations
16.
Sugiki, Masahiko, et al.. (1998). Inhibition of a snake venom hemorrhagic metalloproteinase by human and ratα-macroglobulins. Toxicon. 36(8). 1127–1139. 22 indexed citations
17.
Yoshida, Etsuo, et al.. (1995). Prostate‐specific antigen activates single‐chain urokinase‐type plasminogen activator. International Journal of Cancer. 63(6). 863–865. 48 indexed citations
18.
Mihara, Hisashi, et al.. (1991). A Novel Fibrinolytic Enzyme Extracted from the Earthworm, Lumbricus rubellus.. The Japanese Journal of Physiology. 41(3). 461–472. 210 indexed citations
19.
Yoshida, Etsuo, Hiroyuki Sumi, Hirofumi Tsushima, Masugi Maruyama, & Hisashi Mihara. (1991). Distribution and localization of inter-?-trypsin inhibitor and its active component acid-stable proteinase inhibitor: Comparative immunohistochemical study. Inflammation. 15(1). 71–79. 23 indexed citations
20.
Sumi, Hiroyuki, et al.. (1987). Development and application of an enzyme-linked immunosorbent assay for acid stable trypsin inhibitor (ASTI) in human plasma. Clinica Chimica Acta. 167(2). 155–164. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Luíza Vilela Oliva Breakdown of academic impact, for papers by Xiaoying Chen Breakdown of academic impact, for papers by Tianyuan Zhang Breakdown of academic impact, for papers by M. NAKAYAMA Breakdown of academic impact, for papers by Muhammad Tariq Breakdown of academic impact, for papers by Liying Liu Breakdown of academic impact, for papers by Miroslav Blumenberg Breakdown of academic impact, for papers by Mauro S.G. Pavão Breakdown of academic impact, for papers by Jin Yang Breakdown of academic impact, for papers by Wentao Dai
Rankless by CCL
2026